NCT02609230 2021-06-04A Dose-Escalation Study of Onc201 Administered Every One or Three Weeks in Advanced Solid Tumors and Multiple MyelomaFox Chase Cancer CenterPhase 1 Completed33 enrolled
NCT03492138 2020-05-29Ixazomib, ONC201, and Dexamethasone in Relapsed/Refractory Multiple MyelomaIcahn School of Medicine at Mount SinaiPhase 1/2 Terminated5 enrolled